GASTROINTESTINAL STROMAL CANCER

GASTROINTESTINAL STROMAL CANCER was reported 42 times

GASTROINTESTINAL STROMAL CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
1 alpha-Adrenergic Blocker [EPC] 2 0.0000
2 Potassium Channel Blocker [EPC] 1 0.0000
3 Androgen Receptor Inhibitor [EPC] 1 0.0000
4 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 5 0.0000
6 Aromatase Inhibitor [EPC] 1 0.0000
7 Factor Xa Inhibitor [EPC] 2 0.0000
8 beta-Adrenergic Blocker [EPC] 2 0.0000
9 Thiazide Diuretic [EPC] 1 0.0000
10 Progestin [EPC] 1 0.0000
11 Vitamin D [EPC] 1 0.0000
12 Vitamin B12 [EPC] 1 0.0000
13 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
14 Vitamin C [EPC] 1 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
16 Loop Diuretic [EPC] 1 0.0000
17 Corticosteroid [EPC] 1 0.0000